Clinical Trials Browser

Terminated × selinexor × Other hematologic neoplasm × Clear all

NCT06449482 2025-05-30

Selinexor、Venetoclax and Azactidine in the Treatment of ND AML Patients Who Are Not Eligible for Intense Chemotherapy

Phase 1/2 Terminated

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT03071276 2020-05-22

Selinexor in Combination With Fludarabine and Cytarabine in Patients With Refractory or Relapsed Acute Myeloid Leukemia

Phase 2 Terminated

37 enrolled 11 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute